Overall rank by patents
#20,117
of 50,000 tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 17 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B23Q (DETAILS, COMPONENTS, OR ACCESSORIES FOR MACHINE TOOLS, e.g. ARRANGEMENTS FOR COPYING OR CONTROLLING ; MACHINE TOOLS IN GENERAL CHARACTERISED BY THE CONSTRUCTION OF PARTICULAR DETAILS OR COMPONENTS; CO).
The verdict
According to USPTO PatentsView, Nakamura-tome ranks #20,117 of 50,000 tracked US assignees by granted-patent volume, with 14 patents across 17 technology areas.
USPTO PatentsView assignee plate
Corpus R20117 · Foreign Corporation #20,117 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Morphic Therapeutic, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Nakamura-tome Precis… · this assignee
29 score
3D Lighting Innovati… · lowest
7 score
What this shows Nakamura-tome Precision Industry Co., Ltd. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-SPARSE, TYPE-FRNCORP, VEL-FLAT, BOOK-FULL. Volume places it #20,117 of 50,000; Innovation Score 29.0/100 sits in the top 71% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Morphic Therapeutic, Inc. (±0 grants).
Nakamura-tome Precision Industry Co., Ltd. has been granted 14 US utility patents between 2018 and 2024, placing Nakamura-tome Precision Industry Co., Ltd. at #20,117 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.6 claims per patent with primary concentration in B23Q (DETAILS, COMPONENTS, OR ACCESSORIES FOR MACHINE TOOLS, e.g. ARRANGEMENTS FOR COPYING OR CONTROLLING ; MACHINE TOOLS IN GENERAL CHARACTERISED BY THE CONSTRUCTION OF PARTICULAR DETAILS OR COMPONENTS; CO). As a Foreign Corporation, Nakamura-tome Precision Industry Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Nakamura-tome sits between Morphic Therapeutic, Inc. (14 patents, rank #20,110) and Nanowear Inc. (14 patents, rank #20,118) - the closest US assignees by grant volume. The composite Innovation Score of 29.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 7 grants, compared with 7 in the 2015–2019 window, a +0% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Nakamura-tome Precision Industry Co., Ltd.'s 5.6 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 17 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Morphic Therapeutic, Inc.
14 patents
Multi-Color Corporation
14 patents
Multiquip Inc.
14 patents
NAC International Inc.
14 patents
NANJING DRUM TOWER HOSPITAL
14 patents
NANOBACTERIE
14 patents
NANOGRID LIMITED
14 patents
NANOWEAR INC.
14 patents
NAKAMURA-TOME PRECISION INDUSTRY CO., LTD.
14 patents
What this shows Nakamura-tome holds 14 patents at rank #20,114, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,114 in granted patent volume.
Other assignees with the most granted patents in Nakamura-tome's primary technology class.
Nakamura-tome's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 Top 71% higher than 29% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 4 | 28.6% |
| 2019 | 3 | 21.4% |
| 2020 | 1 | 7.1% |
| 2021 | 4 | 28.6% |
| 2022 | 1 | 7.1% |
| 2024 | 1 | 7.1% |
Top 15 of 17 technology areas
Overall rank by patents
#20,117
of 50,000 tracked assignees
29.0 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.